OyaGen
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1200 Jefferson Rd Ste 206, Rochester, Ne...Website
www.oyageninc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About OyaGen
OyaGen is a preclinical drug discovery and development company focused on identifying novel therapeutic solutions for infectious diseases and cancer. The company specializes in developing antiretroviral lead compounds for HIV, as well as treatments for Ebola and COVID-19. OyaGen offers fee-for-service capabilities in drug discovery, including assay development and consulting services for academic and industry partners. The company aims to partner with pharmaceutical leaders for clinical development and is seeking collaborators for its drug discovery services.Explore more
OyaGen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OyaGen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when OyaGen launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on OyaGen recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at OyaGen
OyaGen, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if OyaGen is spiking on competitors!
Funding: Get notified immidiatlly once OyaGen has new funding data
Click to see if OyaGen had a recent Job posting/layoffs
Check if OyaGen has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at OyaGen
Find more new buyers
Compare Similar Companies to OyaGen
Compare insights from companies similar to OyaGen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OyaGen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OyaGen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OyaGen.
OyaGen financials insights
Gather financial insights about OyaGen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Private Equity
$1M
2010
Unspecified
$500K
2012
Private Equity
$1.7M
2021
Debt
$51K
OyaGen Tech Stack
A closer look at the technologies used by OyaGen
See more technologies
OyaGen News & Media
Tonix Pharmaceuticals Enters into Exclusive Worldwide Licensing Agreement with OyaGen to Develop Antiviral SARS-CoV-2 Inhibitor, TNX-3500, for the Treatment of COVID-19
Early Studies Show TNX-3500 Significantly Inhibits SARS-CoV-2, the Cause of COVID-19, and Potentiates Remdesivir Early Studies Show TNX-3500 Significantly Inhibits SARS-CoV-2, the Cause of COVID-19, and Potentiates RemdesivirTonix Pharmaceuticals Enters into Exclusive Worldwide Licensing Agreement with OyaGen to Develop Antiviral SARS-CoV-2 Inhibitor, TNX-3500, for the Treatment of COVID-19
Early Studies Show TNX-3500 Significantly Inhibits SARS-CoV-2, the Cause of COVID-19, and Potentiates Remdesivir Early Studies Show TNX-3500 Significantly Inhibits SARS-CoV-2, the Cause of COVID-19, and Potentiates RemdesivirOyagen, Inc. Publishes Study On Its OYA1 As A "Highly Effective" Experimental Drug Candidate For Treating Infections By The Ebola Virus
ROCHESTER, N.Y., Jan. 7, 2021 /PRNewswire/ -- OyaGen, Inc. announced today publication in VIRUSES, a peer reviewed journal, of studies carried out by OyaGen in collaboration with NIH/NIAID Integrated Research Facility at Fort Detrick MD. This Study identified OYA1 as a "highly effective"...OyaGen, Inc. Announces a Compound in Development with Broad Antiviral Activity Against Coronaviruses, including SARS-CoV-2
ROCHESTER, N.Y., March 11, 2020 /PRNewswire/ -- OyaGen, Inc. announced today new unpublished results from collaborative research with the National Institute of Allergy and Infectious Diseases' Integrated Research Facility at Fort Detrick, MD, suggesting strong dose-dependent antiviral...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding OyaGen
Sign Up For FreeTo access detailed company insights
OyaGen is a preclinical drug discovery and development company focused on identifying novel therapeutic solutions for infectious diseases and cancer. The company specializes in developing antiretroviral lead compounds for HIV, as well as treatments for Ebola and COVID-19. OyaGen offers fee-for-service capabilities in drug discovery, including assay... Read More
